Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression. - Wikidata - awgldk - TriplyDB

Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

http://www.wikidata.org/entity/Q51893845

about

The clinical use of structural MRI in Alzheimer disease Brain imaging in Alzheimer disease Pain in people with Alzheimer disease: potential applications for psychophysical and neurophysiological research Using structural and diffusion magnetic resonance imaging to differentiate the dementias.Brain imaging in dementia.Biomarkers in translational research of Alzheimer's disease Using NMR approaches to drive the search for new CNS therapeutics.Differences in age-related effects on brain volume in Down syndrome as compared to Williams syndrome and typical development.Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.Quantitative structural MRI for early detection of Alzheimer's disease.Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease.Regional shape abnormalities in mild cognitive impairment and Alzheimer's disease Differential processing of natural scenes in posterior cortical atrophy and in Alzheimer's disease, as measured with a saccade choice task Six-month atrophy in MTL structures is associated with subsequent memory decline in elderly controls Current and emerging drug treatment options for Alzheimer's disease: a systematic review.Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study.Enrichment and stratification for predementia Alzheimer disease clinical trials.Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry Mapping ventricular expansion onto cortical gray matter in older adults.Genetic influence of apolipoprotein E4 genotype on hippocampal morphometry: An N = 725 surface-based Alzheimer's disease neuroimaging initiative study.Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer's disease Vascular imaging abnormalities and cognition: mediation by cortical volume in nondemented individuals: atherosclerosis risk in communities-neurocognitive study.Biomarkers in Alzheimer's disease.Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.Evaluation of Cross-Protocol Stability of a Fully Automated Brain Multi-Atlas Parcellation Tool.Shape abnormalities of subcortical and ventricular structures in mild cognitive impairment and Alzheimer's disease: detecting, quantifying, and predicting.Discriminant analysis of intermediate brain atrophy rates in longitudinal diagnosis of Alzheimer's disease Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy.Surface-based TBM boosts power to detect disease effects on the brain: an N=804 ADNI study.A review on neuroimaging-based classification studies and associated feature extraction methods for Alzheimer's disease and its prodromal stages.Laminar specific detection of APP induced neurodegeneration and recovery using MEMRI in an olfactory based Alzheimer's disease mouse model Surface fluid registration of conformal representation: application to detect disease burden and genetic influence on hippocampus Magnetic resonance imaging volume of the angular gyri predicts financial skill deficits in people with amnestic mild cognitive impairment MRI volume of the medial frontal cortex predicts financial capacity in patients with mild Alzheimer's disease.Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition Genetic interactions within inositol-related pathways are associated with longitudinal changes in ventricle size.Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort.Subregional neuroanatomical change as a biomarker for Alzheimer's disease.Clinical applications of neuroimaging in patients with Alzheimer's disease: a review from the Fourth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.

P2860

Q24609648-94B9DD9F-BD5D-45DE-9182-C4D108A41C76 Q26996299-6AD3F4F9-8E92-4265-9322-1E9319E836B6 Q27022527-E9CF36CF-67DD-40E8-9319-6E7D09CC19BF Q30836806-66F6DBAC-6EBE-4E25-8D55-E5298A0BCA59 Q31051218-9A2A994D-1F29-42D9-BCFA-D04BFCA48A43 Q33556189-B15336CE-B6CB-4F29-88D8-3516A2C2024E Q33613767-DEAC0DFC-1BB7-4B84-81FB-28C4961C4D76 Q33617052-CAF9A2E1-EB00-447C-A170-1BF9E542F15A Q33652639-0FE7B623-1A73-4822-834C-083047D9F48C Q33729033-61E5754B-EB0F-4E78-ACA4-B067F47A1A78 Q33754677-5D124B81-F4BA-489E-83EA-3D570BEB3E6E Q33762662-103CBC1E-E0AD-4BBF-8091-A2D5902B60EE Q33950623-6A6376D2-643C-4EF3-B460-D0D6EC9AF371 Q34126757-9FDD433D-F313-4792-92ED-47CFAED0FDFC Q34222721-9BCD0FC0-8AC9-4F07-A31A-63476A07EA74 Q34392882-23A677BF-34FC-41E5-8F31-051BA6025E26 Q34452239-CB1B826C-9469-4F08-88D2-90D5ED44717D Q34615211-4528FD07-88BE-4A59-8BD4-BC57B4BCDFBA Q34714892-3E065AB8-F86A-4003-ACD3-D8851D0CE004 Q34725320-8F3E8D16-DF7B-4D3F-BE10-C96A21CCBC4D Q34746705-5F5FFCB4-D4DF-4D61-96F6-F690D39F6F66 Q35019559-2D26D780-78F7-4888-878F-843C21951A41 Q35113795-CF813C05-E94E-485B-A924-6295FF22EFAA Q35401597-1077BA70-C486-4B54-BE5E-8957B186EF9B Q35712235-94B0E823-7B16-4B27-9502-4CC047B33E83 Q35759912-3D4605FC-0D75-4B54-9C42-EE591DEDD73B Q35834897-36AB512C-7D2D-4147-8FE5-A3449D661B7D Q35905639-2BB69DAB-9F9D-4F0B-98DD-D27BE302DC2B Q36087030-8A15A7F4-15BA-45B9-A6E3-6FE3CD0D8081 Q36348208-FAFC445D-DBCF-464D-A295-6C1C69B831E3 Q36519498-D7448525-DD14-45DA-B8AC-4E010D2E9FF8 Q36932677-F01F4E5F-CF70-4356-9FF3-9A38C0F0F94D Q37011973-DA43E33A-3B4A-4069-A2DA-9ABD1F0A0C15 Q37028247-3CEE6D4A-3018-4609-9133-6D43FA3A5B75 Q37228160-5877C73B-F6BF-43A2-B5C3-57675574F35F Q37273916-24E8F99C-08A5-4693-866C-6071BDA1AF6F Q37300216-7CF49BA6-8CC4-4CA9-8302-78C5CCA38942 Q37394321-0925A10F-1D08-4E9B-B1D6-BA62FB47F2D7 Q37469614-2388ACBF-079A-4142-A3E8-E6D36BA57E58 Q37693470-19CDEBED-1AC3-4970-BABB-F51B1D4BF923

P2860

Volumetric MRI and cognitive measures in Alzheimer disease : comparison of markers of progression.

http://www.wikidata.org/entity/Q51893845

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Volumetric MRI and cognitive m ...... son of markers of progression.

@en

Volumetric MRI and cognitive m ...... son of markers of progression.

@nl

type

label

Volumetric MRI and cognitive m ...... son of markers of progression.

@en

Volumetric MRI and cognitive m ...... son of markers of progression.

@nl

prefLabel

Volumetric MRI and cognitive m ...... son of markers of progression.

@en

Volumetric MRI and cognitive m ...... son of markers of progression.

@nl

P1433

Q51893845-8DD298CD-8BFB-4802-8BBA-6A4022020FE6

P1476

Q51893845-B938E13E-194E-4490-886E-B37E98CAE791

P2093

Q51893845-44BCFD50-8E94-47EA-A49D-E9BF75FE184D

Q51893845-5C20C8FF-6916-4CE5-9976-30C9A9877BFB

Q51893845-6844F3B7-9B4A-4DA6-AD78-B07973E8261B

Q51893845-716AC33C-685C-4CEE-8889-920CF92D8950

Q51893845-9D211EF6-A2CA-4CEC-90F4-096EDBFB4CF3

Q51893845-CC506F9E-7B40-4915-A2BA-E8631CCC94D7

Q51893845-EA269A44-FD46-4F5A-A24F-6B07346177E3

P2860

Q51893845-1039E838-5AB0-475C-A390-AC54914F805C

Q51893845-43686E51-2130-4CE4-ACD7-EFF4799E5076

Q51893845-590BBC19-9943-415E-AB75-54DFEFF3A9A1

Q51893845-6DF05AFD-D71C-41CD-9ED0-206C1711A3AB

Q51893845-7F3DB1DF-94BB-44B5-A357-6467B76A09EF

Q51893845-87D28A22-ED68-4E7C-ADD2-E6F48F1291F6

Q51893845-8F47A3EE-85A6-4DF0-85C5-3E61AA81C1B6

Q51893845-97E9AACD-EDAC-429D-912A-6379DD11B239

Q51893845-E9028DF4-0B8A-4169-9551-37C1024870B4

P2888

Q51893845-2DF4146F-2C1A-4E00-8F88-4CE9721BA68E

P304

Q51893845-B7E6CDF3-839E-4FE0-9932-383ACF874B70

P31

Q51893845-FEC2F731-17CB-4C9A-AE18-315C3A066334

P356

Q51893845-37293E11-6D21-4500-B811-600888F0AD23

P433

Q51893845-2DD088D0-6970-4CEA-9D1B-2E7FDD25A6F5

P478

Q51893845-42BFB6A7-6BF6-4C73-9EFB-31FDE539BE4B

P50

Q51893845-0D28B6EE-7F51-43F6-B6AA-065BDC7B41C1

Q51893845-63C99218-367A-41E9-A608-7D2E6E09AFEC

Q51893845-8E40D6D8-83D1-41A7-BD2A-56A134165587

Q51893845-F38DA7EF-D48E-401A-8143-22CD5D07C116

P577

Q51893845-674A9584-B23D-4514-A4C1-8F75EB4C2663

P698

Q51893845-F6CDCEBE-7D5F-49C7-832D-497E97DEE149

P356

S00415-008-0750-9

P1433

Journal of Neurology

P1476

Volumetric MRI and cognitive m ...... son of markers of progression.

@en

P2093

Basil H Ridha

http://www.w3.org/2001/XMLSchema#string

Jennifer L Whitwell

http://www.w3.org/2001/XMLSchema#string

Lisa Jenkins

http://www.w3.org/2001/XMLSchema#string

Micheal Grundman

http://www.w3.org/2001/XMLSchema#string

Richard G Boyes

http://www.w3.org/2001/XMLSchema#string

Ronald S Black

http://www.w3.org/2001/XMLSchema#string

Shona L Price

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

The Clinical Dementia Rating (CDR): current version and scoring rules

Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease.

Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease.

Correlation between rates of brain atrophy and cognitive decline in AD.

MR-based hippocampal volumetry in the diagnosis of Alzheimer's disease.

A new rating scale for Alzheimer's disease.

Temporal lobe regions on magnetic resonance imaging identify patients with early Alzheimer's disease.

P2888

s00415-008-0750-9

P304

567-574

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00415-008-0750-9

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

255

http://www.w3.org/2001/XMLSchema#string

P50

Josephine Barnes

Valerie M Anderson

P577

2008-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18274807

http://www.w3.org/2001/XMLSchema#string